The Utility of a Composite Biological Endpoint in HIV/STI Prevention Trials

Author: Hartwell Tyler   Pequegnat Willo   Moore Janet   Parker Corette   Strader Lisa   Green Annette   Quinn Thomas   Wasserheit Judith   Klausner Jeffrey  

Publisher: Springer Publishing Company

ISSN: 1090-7165

Source: AIDS and Behavior, Vol.17, Iss.9, 2013-11, pp. : 2893-2901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content